The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / November / Adaptive Sampling Advances Pediatric Cancer Profiling
Oncology Omics Precision medicine Research and Innovations Molecular Pathology

Adaptive Sampling Advances Pediatric Cancer Profiling

Rapid nanopore sequencing identifies cancer mutations within hours, offering a potential alternative to multiple diagnostic tests

11/16/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll

Share

Clinical Scorecard: Adaptive Sampling Advances Pediatric Cancer Profiling

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Adaptive Sampling Advances Pediatric Cancer Profiling
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationPatients or participants described in the source article.
Care SettingDiagnostic laboratory evaluation of pediatric cancers; further clinical validation is needed to establish whether AS-WGS can replace existing diagnostic workflows.

Key Highlights

  • The researchers estimated sequencing costs at approximately CAD $1,700 per sample, compared with more than CAD $5,000 for combined conventional approaches.

Guideline-Based Recommendations

Diagnosis

  • The study evaluated AS-WGS as a single assay for detecting gene fusions, mutations, large copy-number alterations, and DNA methylation patterns in pediatric cancer samples.
  • The researchers developed the open-source nf-core-oncoseq pipeline to support interpretation while sequencing was underway.

Management

  • The lead researcher said earlier molecular profiling could support timely risk stratification and tailored treatment decisions; further clinical validation is needed to establish whether the approach can replace existing workflows and improve treatment decisions.

Monitoring & Follow-up

  • The lead researcher said real-time sequencing and analysis can provide initial clinically relevant insights within hours, with comprehensive molecular profiles available within days.
  • The source reports that detecting low-frequency mutations could require up to 72 hours of sequencing.

Risks

  • Some variants required manual review.
  • DNA quality and sequencing performance affected results.
  • Further clinical validation is needed to establish whether AS-WGS can replace existing diagnostic workflows and improve treatment decisions.

Patient & Prescribing Data

The study included 35 pediatric patients and 36 samples; 31 samples were tumors representing leukemias and solid cancers.

No treatment regimen or prescribing outcomes were reported. The lead researcher stated that earlier molecular profiling could support timely risk stratification and tailored treatment decisions.

Clinical Best Practices

  • Interpret the reported performance in the context of the study's 36 samples and the need for further clinical validation.
  • The source reports that DNA quality and sequencing performance affected results.
  • Some variants required manual review.
  • The source reports that detecting low-frequency mutations could require up to 72 hours of sequencing.

Related Resources & Content

  • Genome Medicine study on adaptive sampling whole-genome sequencing in pediatric cancer (article title not provided in source)

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.